Pricing
Login
Home
Charts
Search
Watchlist
Products

Influx Healthtech Ltd

INFLUX
₹285.00+2.48%20 Nov 2026
Reports
Pharma Formulations

Influx Healthtech Ltd

INFLUX
₹285.00
+2.48%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹660Cr
Close
Close Price
₹285.00
Industry
Industry
Pharma Formulations
PE
Price To Earnings
29.26
PS
Price To Sales
3.99
Revenue
Revenue
₹165Cr
Rev Gr TTM
Revenue Growth TTM
—
PAT Gr TTM
PAT Growth TTM
—

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2025Mar 2026Sep 2026
Revenue
RevenueCr
678085
Growth YoY
Revenue Growth YoY%
27.9
Expenses
ExpensesCr
526567
Operating Profit
Operating ProfitCr
151518
OPM
OPM%
22.019.021.5
Other Income
Other IncomeCr
010
Interest Expense
Interest ExpenseCr
000
Depreciation
DepreciationCr
222
PBT
PBTCr
151619
Tax
TaxCr
344
PAT
PATCr
101112
Growth YoY
PAT Growth YoY%
20.0
NPM
NPM%
15.013.214.1
EPS
EPS₹
4.84.55.2
QuarterSep 2025Mar 2026Sep 2026
Revenue
RevenueCr
678085
Growth YoY
Revenue Growth YoY%
27.9
Expenses
ExpensesCr
526567
Operating Profit
Operating ProfitCr
151518
OPM
OPM%
22.019.021.5
Other Income
Other IncomeCr
010
Interest Expense
Interest ExpenseCr
000
Depreciation
DepreciationCr
222
PBT
PBTCr
151619
Tax
TaxCr
344
PAT
PATCr
101112
Growth YoY
PAT Growth YoY%
20.0
NPM
NPM%
15.013.214.1
EPS
EPS₹
4.84.55.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2026TTM
Revenue
RevenueCr
147165
Growth
Revenue Growth%
Expenses
ExpensesCr
117132
Operating Profit
Operating ProfitCr
3034
OPM
OPM%
20.320.3
Other Income
Other IncomeCr
12
Interest Expense
Interest ExpenseCr
00
Depreciation
DepreciationCr
44
PBT
PBTCr
2735
Tax
TaxCr
77
PAT
PATCr
2123
Growth
PAT Growth%
NPM
NPM%
14.013.6
EPS
EPS₹
9.39.7
Financial YearMar 2026TTM
Revenue
RevenueCr
147165
Growth
Revenue Growth%
Expenses
ExpensesCr
117132
Operating Profit
Operating ProfitCr
3034
OPM
OPM%
20.320.3
Other Income
Other IncomeCr
12
Interest Expense
Interest ExpenseCr
00
Depreciation
DepreciationCr
44
PBT
PBTCr
2735
Tax
TaxCr
77
PAT
PATCr
2123
Growth
PAT Growth%
NPM
NPM%
14.013.6
EPS
EPS₹
9.39.7
Avg. ROCE
1 Year27%
3 Years-
5 Years-
TTM31%
CFO / EBITDA
1 Year13%
3 Years-
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2026Sep 2026
Equity Capital
Equity CapitalCr
2323
Reserves
ReservesCr
7890
Current Liabilities
Current LiabilitiesCr
23
Non Current Liabilities
Non Current LiabilitiesCr
0
Total Liabilities
Total LiabilitiesCr
124141
Current Assets
Current AssetsCr
81
Non Current Assets
Non Current AssetsCr
42
Total Assets
Total AssetsCr
124141
Financial YearMar 2026Sep 2026
Equity Capital
Equity CapitalCr
2323
Reserves
ReservesCr
7890
Current Liabilities
Current LiabilitiesCr
23
Non Current Liabilities
Non Current LiabilitiesCr
0
Total Liabilities
Total LiabilitiesCr
124141
Current Assets
Current AssetsCr
81
Non Current Assets
Non Current AssetsCr
42
Total Assets
Total AssetsCr
124141

Cash Flow

Consolidated
Standalone
Financial YearMar 2026
Operating Cash Flow
Operating Cash FlowCr
4
Investing Cash Flow
Investing Cash FlowCr
-25
Financing Cash Flow
Financing Cash FlowCr
45
Net Cash Flow
Net Cash FlowCr
23
Free Cash Flow
Free Cash FlowCr
-21
CFO To PAT
CFO To PAT%
18.9
CFO To EBITDA
CFO To EBITDA%
13.0
Financial YearMar 2026
Operating Cash Flow
Operating Cash FlowCr
4
Investing Cash Flow
Investing Cash FlowCr
-25
Financing Cash Flow
Financing Cash FlowCr
45
Net Cash Flow
Net Cash FlowCr
23
Free Cash Flow
Free Cash FlowCr
-21
CFO To PAT
CFO To PAT%
18.9
CFO To EBITDA
CFO To EBITDA%
13.0

Ratios

Consolidated
Standalone
Financial YearMar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
468660
Price To Earnings
Price To Earnings
22.829.3
Price To Sales
Price To Sales
3.24.0
Price To Book
Price To Book
4.66.5
EV To EBITDA
EV To EBITDA
14.818.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.133.1
OPM
OPM%
20.320.3
NPM
NPM%
14.013.6
ROCE
ROCE%
27.231.1
ROE
ROE%
20.420.0
ROA
ROA%
16.616.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
468660
Price To Earnings
Price To Earnings
22.829.3
Price To Sales
Price To Sales
3.24.0
Price To Book
Price To Book
4.66.5
EV To EBITDA
EV To EBITDA
14.818.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.133.1
OPM
OPM%
20.320.3
NPM
NPM%
14.013.6
ROCE
ROCE%
27.231.1
ROE
ROE%
20.420.0
ROA
ROA%
16.616.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr874793782660486435402
Close PriceClose₹94.87147.80223.81285.00406.05762.60285.90
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE17.25278.8732.1629.2620.8915.1432.16
Price To SalesPS2.541.923.283.993.111.151.91
RevenueRevenueCr343414239165156378210
Revenue Growth TTMRev Gr TTM%0.7%13.1%13.9%55.2%19.7%27.5%
PAT Growth TTMPAT Gr TTM%287.7%-68.6%-13.6%39.5%290.6%41.9%
Market CapitalizationMkt CapCr874793782660486435402
Close PriceClose₹94.87147.80223.81285.00406.05762.60285.90
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE17.25278.8732.1629.2620.8915.1432.16
Price To SalesPS2.541.923.283.993.111.151.91
RevenueRevenueCr343414239165156378210
Revenue Growth TTMRev Gr TTM%0.7%13.1%13.9%55.2%19.7%27.5%
PAT Growth TTMPAT Gr TTM%287.7%-68.6%-13.6%39.5%290.6%41.9%
Annual Reports
FY2026
FY2025
Quarterly Reports
FY2026
Annual Reports
Quarterly Reports
Load More
Interviews